Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

427P - Value of magnetic resonance diffusion weighted imaging in the identification of complete responder patients with rectal cancer treated with neoadjuvant therapy

Date

17 Sep 2020

Session

E-Poster Display

Topics

Tumour Site

Colon and Rectal Cancer

Presenters

Juan-ramon Ayuso

Citation

Annals of Oncology (2020) 31 (suppl_4): S409-S461. 10.1016/annonc/annonc270

Authors

J. Ayuso1, C. Pérez-Serrano1, M. Pagés1, S. Rodríguez-Gómez1, T.D. Barreto Zambrano2, C. Conill2, J. Maurel3

Author affiliations

  • 1 Radiology, Hospital Clinic y Provincial de Barcelona, 08036 - Barcelona/ES
  • 2 Oncología Radioterápica, Hospital Clinic y Provincial de Barcelona, 08036 - Barcelona/ES
  • 3 Oncology, Hospital Clinic y Provincial de Barcelona, 08036 - Barcelona/ES

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 427P

Background

The identification of pathologic complete responder (pCR) patients with locally advanced rectal cancer (LARC) after neoadjuvant treatment (NAT) is of interest in terms of patient prognosis and subsequent therapy options. A four-pattern based evaluation combining diffusion weighted imaging (DWI) and tumor morphology on T2-weighted magnetic resonance has shown promising results in identification pCR. Our aim was to evaluate the performance and reproducibility of this approach in a retrospective series in our center.

Methods

Pre and post NAT MRI scans obtained in 120 patients with LARC between 2009 and 2014 were retrospectively evaluated by 2 radiologists with 20 and 3 years of experience respectively. Due to artifacts in DWI, tumoral mucine or absence of pathologic specimen, 79 patients were finally evaluated. Reviewers (R), blinded to pathologic final result, assigned 1 of 4 morphologic and DWI tumoral response patterns to every case, including assessment of the absence or presence of residual tumor.

Results

R1 and R2 identified 6 and 5 of 15 patients with pCR respectively. Assignments of patients to each group and data on sensitivity and specificity both global and per group are listed in the table. Correlation for pattern assignment between both reviewers showed a k=0.68. Table: 427P

Global A B C D
Reviewer 1 2 1 2 1 2 1 2 1 2
n 79 32 23 18 17 26 37 3 2
Sensitivity 97 87 96 80 100 100 94 85 100 100
Specificity 40 33 100 100 0 0 12 20 - -

Conclusions

The identification of residual tumor with DWI in LARC after NAT can be achieved with high sensitivity and modest specificity. Distinguishing morphologic and DWI patterns allow us to select a group with very good results (pattern A) and identify a group in which pCR rarely occur (pattern B). Group classification of patients into each group could be done with good correlation between reviewers. The majority of the discrepancies concentrate in patterns A and C assignments.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.